Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
Buffeted by criticism, the Food and Drug Administration said Friday that it would appoint a director of drug safety and take other actions to assure the safety of medications it approves.
Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
Buffeted by criticism, the Food and Drug Administration said Friday that it would appoint a director of drug safety and take other actions to assure the safety of medications it approves.
Merck &amp; Co. said its surprise decision Thursday to withdraw the arthritis drug Vioxx -- used by about 2 million people worldwide -- was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits.
Less than a week after Merck &amp; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
With Vioxx coming off the pharmacy shelves, what is a patient who took that drug for pain supposed to do?
Merck &amp; Co. said its surprise decision Thursday to withdraw the arthritis drug Vioxx -- used by about 2 million people worldwide -- was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits.
Less than a week after Merck &amp; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
With Vioxx coming off the pharmacy shelves, what is a patient who took that drug for pain supposed to do?
Merck &amp; Co. said its surprise decision Thursday to withdraw the arthritis drug Vioxx -- used by about 2 million people worldwide -- was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits.
Less than a week after Merck &amp; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
With Vioxx coming off the pharmacy shelves, what is a patient who took that drug for pain supposed to do?
Merck &amp; Co. said its surprise decision Thursday to withdraw the arthritis drug Vioxx -- used by about 2 million people worldwide -- was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits.
Less than a week after Merck &amp; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
With Vioxx coming off the pharmacy shelves, what is a patient who took that drug for pain supposed to do?
